SOX9 and cardiac hypertrophy: Ingenuity pathway analysis (IPA) revealed that the WNT/β-catenin, cardiac hypertrophy, hepatic fibrosis, and pulmonary healing pathways were significantly down-regulated in cells with SOX9 shRNAs, suggesting that SOX9 positively regulates these pathways (Fig. 4B).